Discovery of KIN-8741, a highly selective type IIb cMET kinase inhibitor with broad mutation coverage and quality drug-like properties for the treatment of cancer
Ouyang, X.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Hepatocyte growth factor receptor | 309 | Homo sapiens | Mutation(s): 1  Gene Names: MET EC: 2.7.10.1 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P08581 (Homo sapiens) Explore P08581  Go to UniProtKB:  P08581 | |||||
PHAROS:  P08581 GTEx:  ENSG00000105976  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P08581 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
A1AB1 (Subject of Investigation/LOI) Query on A1AB1 | C [auth A], D [auth B] | N-(3,5-difluoro-4-{[6-(2-hydroxyethoxy)-7-methoxyquinolin-4-yl]oxy}phenyl)-4-methoxypyridine-3-carboxamide C25 H21 F2 N3 O6 RKCHWRYEFHSLOC-UHFFFAOYSA-N |
Length ( ? ) | Angle ( ? ) |
---|---|
a = 73.66 | ¦Á = 90 |
b = 69.82 | ¦Â = 95.84 |
c = 78.06 | ¦Ă = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
Aimless | data scaling |
XDS | data reduction |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
Not funded | -- |